Skip to main content

Biotin Interference

April 23, 2018

Recently the consumption of biotin (vitamin B7, component of multivitamins and of hair and nail products, medication for Multiple Sclerosis) has increased and as result the following interfering patterns have been observed:
increased FT4 and decreased TSH mimicking Graves disease or hyperthyroidism; 
decreased PTH with increased vitamin D mimicking PTH suppression or vitamin D intoxication;
increased cortisol with decreased ACTH mimicking hypercortisolism (1)

Because some immunoassays will show falsely decreased (TSH, CA 125, prolactin, F-PSA, NT-PBNP) while others falsely increased values (T3, FT4, cortisol, estradiol, folate) some interference combinations can mimic certain disease states that will not match the clinical picture, and consultation with the laboratory is recommended. T-messages explaining the possible interference will be attached to the results that could be affected.

Risk to Patient:
Although present in literature these interferences are rare: the patients at the highest risk of misdiagnosis are 
consumers of high dose of biotin (Multiple Sclerosis, or oncology patients 100,000 mcg/day)
patients who take increased amounts of pure biotin or beauty products (5,000 to 10,000 mcg/tablet),
patients who take biotin in an moderate amount but have kidney failure who having a delayed clearance of the vitamin.

Biotin, vitamin B7 or vitamin H is a water-soluble vitamin eliminated through the kidney with a half-life between 8 and 24 hours, variable from person to person and increased with kidney failure. Because biotin deficiency is considered extremely rare, no RDI exists. Suggested biotin intake for adults ranges from 30 – 100 mcg per day. Standard multivitamins contain usually 30-50 mcg/tablet, amount will not interfere with our testing, while the beauty products and the MS medication might produce interference.

We recommend asking the patient if he/she is taking treatment, multivitamins or beauty products containing biotin. 
A 12 hour abstinence would ensure the clearance of biotin to a level that would not interfere with our results if the patient takes regular multivitamins or beauty supplements. 
For patients taking doses exceeding 5,000 mcg/day (usually MS treatment) a longer period of abstinence as well as consultation with the laboratory is recommended.
The laboratory is able to identify biotin or any other interferences, communication with the laboratory is recommended whenever the results are discrepant with the clinical picture.

Clinical chemistry testing (electrolytes, glucose, creatinine, lipids, liver enzymes) based mainly on chemical and enzymatic reactions and immunoassays performed on ELISA platforms like lyme, measles, autoimmune assays, or urine pregnancy tests are not affected by biotin but can be    influenced by other interferences.

Our immunoassays are very accurate and reliable but various interferences are possible and a complete list of medication, accurate clinical history as well as a good correlation between the clinical picture and the laboratory results is imperative for patient care. 
The laboratory has methods to identify possible interferences and we are at your service to discuss and follow up on any results that do not have a good clinical explanation, as well as to listen to any questions or suggestions that you might have. 
Please see below some examples of different patterns of thyroid function results and their possible causes.

1.Piketty ML, Polak M et al: False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med 2017; 55 (6): 780-788
2. Koulouri O, Moran C et al: Pitfalls in the measurement and interpretation of thyroid function tests. Best practice & Research Clinical Endocrinology & Metabolism 27 (2013): 745-762


News from Around MaineHealth

View All
MaineHealth signals capacity challenges for health care system likely to continue in the months ahead
Long term trends in the labor market and a surge in demand are making it hard for health care organizations to meet a growing demand for care.
MaineHealth to Require Care Team COVID-19 Vaccinations as Condition of Employment
As MaineHealth seeks to limit the spread of COVID-19, vaccination will be a requirement for employment, with very few exceptions, as of Oct. 1, 2021.
MaineHealth makes significant workforce investment, raising wages for its care team members starting Aug. 8
In addition to a base wage increase for nearly all employees, the minimum pay rate across the health system will rise from $14 to $17 an hour, and market adjustments will be made for hard-to-fill roles.
MaineHealth Administers First Doses of COVID-19 Vaccine to Front-line Caregivers
Hours after the arrival of the Pfizer vaccine at its hospitals, MaineHealth began inoculating team members who provide direct care to patients infected with the novel coronavirus.
MaineHealth Establishes Plan for Inoculating Front-line Care Givers Following State Plan for Distribution of COVID-19 Vaccines
The health system expects to be able to vaccinate all its front-line care team members following the delivery of a second allotment that is expected to include both Pfizer and Moderna vaccines.
MaineHealth’s Access to Care team connects Mainers with coverage during 2021 Open Enrollment
MaineHealth’s Access to Care team is prepared to assist and educate Mainers in shopping for health insurance plans during the Open Enrollment period, which runs November 1 through December 15.
MaineHealth Earns 2020 CHIME Digital Health Most Wired Recognition
The CHIME Digital Health Most Wired program conducts an annual survey to assess how effectively healthcare organizations apply core and advanced technologies into their clinical and business programs to improve health and care in their communities.
MaineHealth Welcomes Susan Ahern, Vice President of Innovation
MaineHealth is pleased to welcome Susan Ahern as Vice President of Innovation, a new systemwide role responsible for planning and development of the MaineHealth Innovation Center.
Top Public Health Official to Join MaineHealth
Dr. Dora Anne Mills, who oversaw the state of Maine’s public health initiatives for 15 years, will lead efforts to create healthier communities for 1.1 million people across Maine and New Hampshire.
Lyme Testing Update
Lyme is one of the endemic disease that plagues New England. One of the manifestations of lyme disease is neuroborreliosis. To help with diagnosis of this affection NorDx is offering the following orderable send-out tests starting June 12th 2018